The Company’s Vx Therapy combines VR technology and customized behavioral therapy to reduce chronic pain and improve recovery for injured workers
Harvard MedTech, a breakthrough digital health company, will host a panel presentation highlighting virtual reality technology and the biopsychosocial approach to patient care at the National Workers’
The session, titled “A Closer Look at How Virtual Reality Produces Real Results for
“Workers’ compensation payers and providers have struggled for decades to find an effective approach to healing the trauma, chronic pain and other effects of workplace injuries,” said
Harvard MedTech’s Vx Therapy is based on new science about how the brain works. The patient uses the virtual reality technology to have positive, engaging experiences that reduce the sensation of pain while the brain builds new neural pathways. The VR therapy is used in the home, and is coupled with personalized behavioral health intervention strategies that teach more skills to permanently lower pain and discomfort that contribute to depression and sleep disorders. With the application of digital health, Vx Therapy is a scalable solution for employers, carriers and risk managers to manage patient populations and contain costs.
The panel features speakers
About Harvard MedTech
Harvard MedTech is a breakthrough digital health company that is tapping the new science of how the brain works, combining specially designed virtual reality experiences, psychosocial support, digital engagement and proprietary AI algorithms to retrain neural pathways and alleviate the effects of trauma, including pain, PTSD, anxiety, depression and sleep disorders. The company’s Vx Therapy model is the first to comprehensively integrate this unique combination of digital technologies with behavioral health interventions, in a virtual application that moves the points of care to the patient’s home. This virtual engagement drives high compliance, patient satisfaction and optimal outcomes. It also allows the solution to be affordable and scalable at a population health level. This non-invasive and non-pharmacological approach also provides data that is trackable for a clear assess of its value to patient and health care providers. Visit www.harvardmedtech.com for more information.
src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20211013005846r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />
Scott Public Relations
Source: Harvard MedTech